Anti-Crk p38 antibody [22/Crk]

7 product images

• 

  Immunoprecipitation - Anti-Crk p38 antibody [22/Crk] (ab300630)

  Crk p38 was immunoprecipitated from 0.35 mg C6 (rat glial tumor glial cell) whole cell lysate with ab300630 at 1/30 dilution (2 µg in 0.35 mg lysates). Western blot was performed on the immunoprecipitate using ab300630 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
  

  Lane 1: C6 (rat glial tumor glial cell) whole cell lysate 10μg (Inset)

  Lane 2: ab300630 at 1/30 IP in C6 whole cell lysate

  Lane 3: Mouse IgG2a, kappa monoclonal isotype control (Mouse IgG2a, Kappa Monoclonal [MOPC-173] -Isotype Control - ChIP Grade ab18413) instead of ab300630 in C6 whole cell lysate

  Blocking and dilution buffer and concentration: 5% NFDM/TBST

  This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.

  ab300630 recognises a band at ~35 KDa (isoform Crk-II) and ~23KDa (isoform Crk-I).

  All lanes: Immunoprecipitation - Anti-Crk p38 antibody [22/Crk] (ab300630) at 1/1000 dilution

  Lane 1: C6 (rat glial tumor glial cell) whole cell lysate at 10 µg

  Lane 2: ab300630 at 1/30 IP in C6 whole cell lysate at 10 µg

  Lane 3: Mouse IgG2a, Kappa Monoclonal [MOPC-173] -Isotype Control - ChIP Grade ab18413 IP in C6 whole cell lysate at 10 µg

  Secondary

  All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/5000 dilution

  Developed using the ECL technique.

  Predicted band size: 33 kDa

  Observed band size: 23 kDa, 35 kDa

  Exposure time: 3min

• 

  Immunoprecipitation - Anti-Crk p38 antibody [22/Crk] (ab300630)

  Crk p38 was immunoprecipitated from 0.35 mg NIH/3T3 (mouse embryonic fibroblast) whole cell lysate with ab300630 at 1/30 dilution (2 µg in 0.35 mg lysates). Western blot was performed on the immunoprecipitate using ab300630 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
  

  Lane 1: NIH/3T3 (mouse embryonic fibroblast) whole cell lysate 10μg (Inset)

  Lane 2: ab300630 at 1/30 IP in NIH/3T3 whole cell lysate

  Lane 3: Mouse IgG2a, kappa monoclonal isotype control (Mouse IgG2a, Kappa Monoclonal [MOPC-173] -Isotype Control - ChIP Grade ab18413) instead of ab300630 in NIH/3T3 whole cell lysate

  Blocking and dilution buffer and concentration: 5% NFDM/TBST

  This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.

  ab300630 recognises a band at ~35 KDa (isoform Crk-II) and ~23KDa (isoform Crk-I).

  All lanes: Immunoprecipitation - Anti-Crk p38 antibody [22/Crk] (ab300630) at 1/1000 dilution

  Lane 1: NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 10 µg

  Lane 2: ab300630 at 1/30 IP in NIH/3T3 whole cell lysate at 10 µg

  Lane 3: Mouse IgG2a, Kappa Monoclonal [MOPC-173] -Isotype Control - ChIP Grade ab18413 IP in NIH/3T3 whole cell lysate at 10 µg

  Secondary

  All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/5000 dilution

  Developed using the ECL technique.

  Predicted band size: 33 kDa

  Observed band size: 23 kDa, 35 kDa

  Exposure time: 3min

• 

  Immunoprecipitation - Anti-Crk p38 antibody [22/Crk] (ab300630)

  Crk p38 was immunoprecipitated from 0.35 mg HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate with ab300630 at 1/30 dilution (2 µg in 0.35 mg lysates). Western blot was performed on the immunoprecipitate using ab300630 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
  

  Lane 1: HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 10μg (Inset)

  Lane 2: ab300630 at 1/30 IP in HeLa whole cell lysate

  Lane 3: Mouse IgG2a, kappa monoclonal isotype control (Mouse IgG2a, Kappa Monoclonal [MOPC-173] -Isotype Control - ChIP Grade ab18413) instead of ab300630 in HeLa whole cell lysate

  Blocking and dilution buffer and concentration: 5% NFDM/TBST

  This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.

  ab300630 recognises a band at ~35 KDa (isoform Crk-II) and ~23KDa (isoform Crk-I).

  All lanes: Immunoprecipitation - Anti-Crk p38 antibody [22/Crk] (ab300630) at 1/1000 dilution

  Lane 1: HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 10 µg

  Lane 2: ab300630 at 1/30 IP in HeLa whole cell lysate at 10 µg

  Lane 3: Mouse IgG2a, Kappa Monoclonal [MOPC-173] -Isotype Control - ChIP Grade ab18413 IP in HeLa whole cell lysate at 10 µg

  Secondary

  All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/5000 dilution

  Developed using the ECL technique.

  Predicted band size: 33 kDa

  Observed band size: 23 kDa, 35 kDa

  Exposure time: 3min

• 

  Western blot - Anti-Crk p38 antibody [22/Crk] (ab300630)

  Blocking and diluting buffer and concentration: 5% NFDM/TBST
  The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID: 8943292).
  
  ab300630 recognises a band at ~35 KDa (isoform Crk-II) and ~23KDa (isoform Crk-I).
  Exposure time: Lanes 1-4:15 seconds
  Lanes 5-8: 8 seconds

  All lanes: Western blot - Anti-Crk p38 antibody [22/Crk] (ab300630) at 1/1000 dilution

  Lane 1: HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate 10 µg

  Lane 2: K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate 10 µg

  Lane 3: HepG2 (human hepatocellar carcinoma epithelial cell), whole cell lysate 10 µg

  Lane 4: Ramos (human Burkitts lymphoma B lymphocyte), whole cell lysate 10 µg

  Lane 5: Jurkat (human T cell leukemia T lymphocyte), whole cell lysate 10 µg

  Lane 6: C6 (rat glial tumor glial cell), whole cell lysate 10 µg

  Lane 7: RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage), whole cell lysate 10 µg

  Lane 8: PC-12 (rat adrenal gland pheochromocytoma), whole cell lysate 10 µg

  Secondary

  All lanes: Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution

  Observed band size: 35 kDa, 23 kDa

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Crk p38 antibody [22/Crk] (ab300630)

  Immunofluorescent analysis of 100% methanol-fixed, 0.1% TritonX-100 permeabilized C6 (rat glial tumor glial cell) cells labelling Crk p38 with ab300630 at 1/50 (20ug/mL) dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed ab150117 Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/mL dilution (Green). Confocal image showing cytoplasmic and nuclear staining in C6 cell line is observed. Anti-beta Tubulin antibody [EPR16774] ab179513 Anti-beta Tubulin rabbit monoclonal antibody was used to counterstain tubulin at 1/200 10 ug/mL dilution (Red). The Nuclear counterstain was DAPI (Blue).
  Secondary antibody only control: Secondary antibody is Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed ab150117 Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/mL dilution.

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Crk p38 antibody [22/Crk] (ab300630)

  Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HeLa (human cervix adenocarcinoma epithelial cell) cells labelling Crk p38 with ab300630 at 1/50 (20ug/mL) dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed ab150117 Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/mL dilution (Green). Confocal image showing cytoplasmic and nuclear staining in HeLa cell line is observed. Anti-beta Tubulin antibody [EPR16774] ab179513 Anti-beta Tubulin rabbit monoclonal antibody was used to counterstain tubulin at 1/200 10 ug/mL dilution (Red). The Nuclear counterstain was DAPI (Blue).
  Secondary antibody only control: Secondary antibody is Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed ab150117 Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/mL dilution.

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Crk p38 antibody [22/Crk] (ab300630)

  Immunofluorescent analysis of 100% methanol-fixed, 0.1% TritonX-100 permeabilized RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) cells labelling Crk p38 with ab300630 at 1/50 (20ug/mL) dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed ab150117 Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/mL dilution (Green). Confocal image showing cytoplasmic and nuclear staining in RAW 264.7 cell line is observed. Anti-beta Tubulin antibody [EPR16774] ab179513 Anti-beta Tubulin rabbit monoclonal antibody was used to counterstain tubulin at 1/200 10 ug/mL dilution (Red). The Nuclear counterstain was DAPI (Blue).
  Secondary antibody only control: Secondary antibody is Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed ab150117 Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/mL dilution.